TMEM154 polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

Details for Australian Patent Application No. 2009325878 (hide)

Owner Novik, A. Compugen Ltd.

Inventors Levine, Zurit; Rosenberg, Avi Yeshah; Rotman, Galit; Toporik, Amir; Kinar, Yaron; Nemzar, Sergey; Cohen-Dayag, Anat; Walach, Shira; Sameach-Greenwald, Shirley; Dassa, Liat; Beiman, Merav; Montia, Eve; Levy, Ofer

Agent Shelston IP

Pub. Number AU-A-2009325878

PCT Pub. Number WO2010/067308

Priority 61/120,540 08.12.08 US

Filing date 8 December 2009

Wipo publication date 17 June 2010

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/067308 Priority application(s): WO2010/067308

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009325879-Method for producing beta-santalene

2009325861-Single piece re-closable unit pack